July 12, 2021
RegMed Investors’ (RMi) pre-open: Watching the rain come down
July 9, 2021
RegMed Investors’ (RMi) pre-open: Christmas in July or is there no gas for the grill?
July 8, 2021
RegMed Investors’ (RMi) pre-open: still staring into the abyss
July 7, 2021
RegMed Investors’ (RMi) pre-open: which way to the upside, it’s a crooked route
July 6, 2021
RegMed Investors’ (RMi) pre-open: fairly quiet, some bounces after Friday’s decline
July 2, 2021
RegMed Investors’ (RMi) pre-open: awaiting the jobs report and how many payrolls American employers added last month.
July 1, 2021
RegMed Investors’ (RMi) pre-open: what a difference news makes
June 30, 2021
RegMed Investors’ (RMi) pre-open: last trading day of 1st half, June and Q2
June 29, 2021
RegMed Investors’ (RMi) pre-open: reduce risk from new highs
June 28, 2021
RegMed Investors’ (RMi) pre-open: Q2 is coming to a close
June 24, 2021
RegMed Investors’ (RMi) pre-open: vulnerable to volatility post highs
June 23, 2021
RegMed Investors’ (RMi) pre-open: a cautious outlook
June 22, 2021
RegMed Investors’ (RMi) pre-open: market and sector realities: fear and risk
June 21, 2021
RegMed Investors’ (RMi) pre-open: after taking the Friday hits, it’s time to rebound
June 18, 2021
RegMed Investors’ (RMi) pre-open: the witch is on the stick
June 17, 2021
RegMed Investors’ (RMi) pre-open: uncertainty as liquidity of pricing reflects conflicted value
June 16, 2021
RegMed Investors’ (RMi) pre-open: Waiting for Powell
June 15, 2021
RegMed Investors’ (RMi) pre-open: are you ready …
June 14, 2021
RegMed Investors’ (RMi) pre-open: The ups of the cell and gene therapy stocks has an impact on the direction of the sector
June 11, 2021
RegMed Investors’ (RMi) pre-open: the sector revels in news
June 10, 2021
RegMed Investors’ (RMi) pre-open: are we worried?
June 9, 2021
RegMed Investors’ (RMi) pre-open: watch your “six’, volatility bites
June 8, 2021
RegMed Investors’ (RMi) pre-open: I question sustainability and stability of sector share pricing
June 7, 2021
RegMed Investors’ (RMi) pre-open: risk, not too hot but, not to cool to ponder moves
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.